Publications by authors named "N Kogan"

Article Synopsis
  • * This study focuses on the anti-Candida effects of newly synthesized derivatives of AbnCBD, which were evaluated for their ability to inhibit the growth of various Candida species, using both lab tests and mouse experiments.
  • * Results indicate that certain AbnCBD derivatives, particularly comp 3, significantly reduced the growth of multiple Candida strains, including resistant ones, disrupted biofilm formation, and showed effectiveness in reducing Candida levels in a mouse model, suggesting their potential as antifungal treatments. *
View Article and Find Full Text PDF

Major depressive disorder (MDD) stands as a significant cause of disability globally. Cannabidiolic Acid-Methyl Ester (CBDA-ME) (EPM-301, HU-580), a derivative of Cannabidiol, demonstrates immediate antidepressant-like effects, yet it has undergone only minimal evaluation in psychopharmacology. Our goal was to investigate the behavioral and potential molecular mechanisms associated with the chronic oral administration of this compound in the Wistar Kyoto (WKY) genetic model of treatment-resistant depression.

View Article and Find Full Text PDF

Glioblastoma multiforme (GBM) is the most common type of glioma, with a median survival of 14.6 months post-diagnosis. Understanding the molecular profile of such tumors allowed the development of specific targeted therapies toward GBM, with a major role attributed to tyrosine kinase receptor inhibitors and immune checkpoint inhibitors.

View Article and Find Full Text PDF

The endocannabinoid system is known to be involved in learning, memory, emotional processing and regulation of personality patterns. Here we assessed the endocannabinoid profile in the brains of mice with strong characteristics of social dominance and submissiveness. A lipidomics approach was employed to assess the endocannabinoidome in the brains of Dominant (Dom) and Submissive (Sub) mice.

View Article and Find Full Text PDF

There is growing interest in non-psychoactive phytocannabinoids, namely cannabidiol (CBD), cannabigerol (CBG), and cannabichromene, as potential leads for novel therapeutic agents. In this study, we report on the development of new derivatives in which we methylated either position 4 of olivetol or the phenolic positions of olivetol, or both. We introduce a refinement on previously reported chemical procedures for phytocannabinoid derivatization as well as the biological evaluation of all derivatives in anti-inflammatory in vivo models.

View Article and Find Full Text PDF